SAN DIEGO, Aug. 4, 2014 /PRNewswire/ — As previously announced, MabVax Therapeutics, Inc., a privately held cancer immunotherapy company, and Telik, Inc. (OTCQB: TELK), aclinical stage oncology drug development company, completed a merger transaction pursuant to which MabVax became…

from PR Newswire: Acquisitions, Mergers and Takeovers http://ift.tt/1AOH2Ph
via IFTTT

Publicités